44results about How to "Meet the dosage requirements" patented technology

The invention relates to a traditional Chinese medicine composition for fracture and soft tissue injury and a preparation method thereof. The composition is prepared from the following raw materials, by weight: 25 parts of muskmelon seeds, 20 parts of angelica, 20 parts of Radix Paeoniae, 20 parts of nux vomica, 18 parts of garden balsam stem, 18 parts of safflower, 15 parts of suberect spatholobus stem, 15 parts of epimedium, 15 parts of pseudo-ginseng, 12 parts of licorice, 12 parts of Astragalus, 10 parts of radix sileris, 10 parts of herba lycopi, 9 parts of yam, 8 parts of eucommia, 7 parts of cassia twig, 5 parts of teasel root, 5 parts of drynaria rhizome, 5 parts of peach kernel and 3 parts of dragon's blood. The traditional Chinese medicine composition provided by the invention treates both symptoms and root causes of fracture and soft tissue injury, and has no toxicity or harm to human body, no side effect, low price, simple production and a broad application prospect.

The invention relates to a pantoprazole sodium medicine compound and a preparation technology thereof. The pantoprazole sodium medicine compound is prepared by taking the following raw materials by weight part: 0.5 parts of pantoprazole sodium, 35 parts of astragalus mongholicus, 27 parts of mangnolia officinalis, 18 parts of pinellia ternata and 15 parts of curcuma zedoary. According to the traditional medicine preparation method, after pharmaceutic adjuvants, such as starch or edible cellulose, are added, the medicine is prepared into capsules, tablets, grains, and the like. The pantoprazole sodium medicine compound provided by the invention has the function of treating both principal and secondary aspects of gastric ulcer, is non-toxic and harmless to human body, is free from side effect, is low in cost, is conveniently prepared and is wide in application prospect.

The invention relates to a medicament for allaying a fever of a child, and a preparation method thereof. The medicament is prepared from 30 parts of herba andrographitis, 25 parts of blackend swallowwort root, 25 parts of honeysuckle, 25 parts of fructus forsythia, 20 parts of folium mori, 20 parts of selfheal, 18 parts of cortex albiziae, 18 parts of astragalus membranaceus, 18 parts of scutellaria baicalensis, 15 parts of radix bupleuri, 15 parts of Chinese mahonia stem, 15 parts of ligusticum wallichii, 13 parts of semen raphani, 12 parts of fruit of Chinese wolfberry, 12 parts of liquorice, 10 parts of pinellia ternate, 10 parts of root of red-rooted salvia, 7 parts of peach kernel, 7 parts of cassia twig, 5 parts of root of common peony, 5 parts of rhizoma zingiberis and 3 parts of bamboo leaves. The medicament treats both symptoms and root causes aiming at the fever of the child, is free of poison and harm to a human body, free of side effect, low in price, and simple and convenient to prepare, and has a wide application prospect.

The invention relates to a compound fenticonazole nitrate preparation and an application thereof, belonging to a Chinese and Western compound preparation. The compound preparation is prepared from the following raw materials: 10g of fenticonazole nitrate, 10g of active ingredients of traditional Chinese medicines, 30g of poloxamer 407, 15g of poloxamer 188, 5g of carbomer, 250g of propylene glycol, 150g of glycerol, 5g of sodium benzoate, 0.3g of ethylene diamine tetraacetic acid and 475g of distilled water. The compound medicine disclosed by the invention can be used for treating both symptoms and root causes of vaginitis; and the compound medicine is non-toxic and harmless to human bodies, free from side effect, low in cost, simple and convenient in preparation and broad in application prospect.

The invention relates to fenticonazole nitrate and a synthesis process thereof. The fenticonazole nitrate is a traditional Chinese and western medicine compound preparation and is prepared from the following materials in parts by weight: 20 parts of fenticonazole nitrate, 50 parts of Radix zanthoxyli, 50 parts of radix stemonae, 40 parts of Tuckahoe, 40 parts of pawpaw, 40 parts of dandelion, 35 parts of pericarpium citri reticulatae, 30 parts of Pinellia ternate, 30 parts of mulberry, 25 parts of safflower carthamus, 25 parts of hawthorn, 20 parts of campsis grandiflora, 20 parts of curcuma aromatic, 15 parts of radix angelicae and 15 parts of pericarpium granati. The compound preparation treats both manifestation and root cause of vaginitis, is non-hazardous for a human body, has no side effects, is low in price and convenient and simple to prepare, and has a wide application prospect.

The invention relates to a traditional Chinese medical composition for treatment of traumatic injury, which is prepared with raw materials of the following weight ratio: 20 parts of rheum officinale, 18 parts of lycopodium clavatum, 18 parts of notopterygium roots, 15 parts of eucommia ulmoides, 15 parts of catecholamine, 12 parts of ligusticum wallichii, 12 parts of safflower, 10 parts of pangolin., 10 parts of natural copper, 9 parts of red-rooted salvia, 9 parts of olibanum, 8 parts of myrrh, 6 parts of keel, 5 parts of hematoxylon, 5 parts of teasel roots, 3 parts of drynaria rhizome, 3 parts of honeysuckle and 3 parts of prepared radix aconite. The traditional Chinese medical composition can be used for complete treatment of the traumatic injury, has no toxic, harmful or side effectson the human body and can be prepared easily, and the cost is low. Thus the composition has broad application prospects.

The invention relates to an ibuprofen suspension and a preparation method thereof. The ibuprofen suspension is a Chinese and western compound preparation, a primary medicine of the ibuprofen suspension comprises ibuprofen, the primary medicine is added to auxiliary medicines of the ibuprofen suspension to make the primary medicine suspend in order to prepare a suspension, and the suspension is disinfected and packaged to obtain the ibuprofen suspension. The ibuprofen suspension can simultaneously treat the principle and subordinate symptoms of infantile recurrent respiratory tract infection and infantile fevers, and has the advantages of non-toxicity and innocuousness to human bodies, no side effects, low price, simple preparation and wide application prospect.

The present invention relates to the technical field of food additives and particularly relates to a preservative composition and a use thereof. Every 1000 ml of solvent contains 0.005-0.1 g ethyl p-hydroxybenzoate and 0.005-0.1 g of ethylene diamine tetraacetic acid and is prepared by mixing the two materials. The preservative composition contains the ethyl p-hydroxybenzoate and the ethylene diamine tetraacetic acid at a mass ratio of 0.5-1 : 0.5-1. Compared with the prior art, the preservative composition can produce a strong inhibitory effect for the foodborne pathogen biofilm. The present invention provides a new use of the preservative composition in inhibiting the formation of foodborne pathogen biofilm. The preservative composition can be used for the preparations of drugs, food additives and feed additives inhibiting foodborne pathogen biofilm formation,, provides a new path for the control and clearance of biofilm in the food industry, and thereby provides a reliable protection for food safety.

The invention relates to a compound omeprazole capsule and a preparation method thereof. The capsule is prepared from omeprazole, sodium bicarbonate, crosslinked sodium carboxymethylcellulose, sodium stearyl fumarate, and traditional Chinese medicinal herbal concentrated extracts. The invention also discloses a preparation method of the compound omeprazole capsule. The compound omeprazole capsule can treat both symptoms and root causes of gastric ulcer, and has advantages of good dissolution and powder fluidity, has low toxic and adverse effects, is easily absorbed by human body, and has wide application prospects.

The invention relates to a compound isosorbide mononitrate and a preparation technology thereof. The compound isosorbide mononitrate is prepared from the following raw materials according to parts by weight: 0.3 part of isosorbide mononitrate, 25 parts of astragalus mongholicus, 20 parts of ligusticum wallichii, 15 parts of antler and 12 parts of trichosanthes kirilowii maxim. According to a general medicine preparation method, a starch edible cellulose medical auxiliary material is added to obtain dosage forms, such as capsules, tablets, granules and the like. The compound isosorbide mononitrate composite disclosed by the invention treats both principal and secondary aspect of stenocardia, is nontoxic and harmless to the human body, has the advantages of no side effect, low cost and wide application prospect and is convenient to manufacture.

The invention relates to compound flunarizine hydrochloride and a preparation process thereof. The compound flunarizine hydrochloride is prepared from the following raw materials in part by weight: 0.7 part of flunarizine hydrochloride, 25 parts of root of red-rooted salvia, 20 parts of common burreed rhizome, 18 parts of zedoary, 15 parts of tall gastrodia tuber and 10 parts of glossy privet fruit, starch live edible cellulose serving as a pharmaceutic adjuvant are added according to the conventional pharmaceutic method to prepare formulations such as capsules, tablets, granules and the like. The compound flunarizine hydrochloride medicinal composition addresses both root causes and symptoms on epilepsy, is non-toxic and harmless to human bodies, does not have side effect, is low in cost and easy and convenient to prepare, and has a bright application prospect.

The invention relates to a pharmaceutical composition containing berberine hydrochloride tablets. The pharmaceutical composition is prepared from the following raw materials: 50kg of berberine hydrochloride tablets, 3kg of carboxymethyl starch sodium and 18kg of purified water to prepare 1 million tablets by a conventional method. The compound berberine hydrochloride tablet medicine composition can be used for treating both symptoms and root cause of enterogastritis, is not toxic or harm to human bodies, does not have side effect, is low in price and simple in preparation, and has a wide application prospect.

The invention relates to a Chinese medicine for treating stenocardia, which is prepared by the following raw materials with the weight ratio, astragalus mongholicus 25 parts, red flowers 20 parts, ligusticum wallichii 20 parts, antler 15 parts, fructus ligustri lucidi 12 parts, radix angelicae 10 parts, ginseng 10 parts, coptis chinensis 8 parts, trichosanthes kirilowii maxim 5 parts and radix ophiopogonis 3 parts. After starch edible cellulose medical auxiliary materials are added into the raw materials according to a general pharmaceutical method, capsules, tablets, granules and the like are prepared. The medicine composition treats both principal and secondary aspects of stenocardia, is innocuous and unpoisonous to human bodies, has no side effect, and has low price, convenience in preparation and wide application prospect.

The invention provides a medicine for treating kidney-yang deficiency type morbid leucorrhea, kidney-yin deficiency type morbid leucorrhea, spleen deficiency type morbid leucorrhea, damp-heat type morbid leucorrhea, qi deficiency, yin deficiency, internal heat and liver heat type irregular menstruation symptoms, as well as a formula and a preparation method thereof, wherein the qi deficiency, the yin deficiency, the internal heat, the liver heat type irregular menstruation symptoms and the damp-heat toxins cause stasis of qi and blood and estrangement of branches of channels after a long time, and thus stasis symptom type chronic pelvic inflammation is caused; the deficiency of qi and blood or weakness of kidney qi or insecurity of thoroughfare and conception channels or nutrition loss of embryo cause habitual abortion. The preparation method of the medicine is safe in process, high in efficiency, quick acting, low in cost and convenient in preparation.

The invention relates to a medicine composition for treating recurrent respiratory tract infection of children. The medicine composition is prepared from the following materials in parts by weight: 5 parts of ibuprofen, 20 parts of radix bupleuri, 20 parts of coptis chinensis, 18 parts of Chinese yam, 15 parts of bamboo leaf, 15 parts of radix zanthoxyli, 15 parts of astragalus membranaceus, 12 parts of pinellia ternate, 10 parts of trichosanthes kirilowii maxim, 10 parts of radix angelicae, 5 parts of red flower, 5 parts of radix curcumae, 3 parts of pomegranate bark and 3 parts of liquorice. By virtue of a regular medicine preparing method such as adding starch or edible cellulose into the materials, capsules, tablets or suspensoid can be prepared. The medicine composition can be used for treating both manifestation and root cause of recurrent respiratory tract infection and fever of children, and is non-toxic and harmless to a human body, low in cost, simple to prepare and wide in application prospect.

The invention discloses a new test dropper including a rubber capsule, a dropper and a suction nozzle, the new test dropper is characterized in that the suction nozzle is provided with a bend, and is provided with a plurality of suction ports on the head. The dropper and the suction nozzle are respectively marked with a large and a small scale. The new test dropper has the advantages of being simple in structure, convenient in use, accurate in measurement, beneficial for improving the test quality and work efficiency and the like.

The invention belongs to the field of medical technology and discloses a benorilate vitamin B1 particle for children. The benorilate vitamin B1 particle for children is prepared from 0.3kg of benorilate, 3g of vitamin B1, 2.69g of sucrose, 3g of essence and 0.25g of tartrazine. The invention also discloses a preparation method of the benorilate vitamin B1 particle for children. According to the benorilate vitamin B1 particle for children, a good curative effect is brought to cold fever, the cold fever is not easy to relapse, less toxic and side effects are caused and the preparation process is simple and feasible.

The invention relates to the field of Chinese patent medicine preparations and discloses a Chinese patent medicine for treating children fever. The Chinese patent medicine preparation comprises the following main effective components: rehmannia, blackend swallowwort root, honeysuckle, pogostemon cablin, mint, licorice root, carapax eretmochelyos, dandelion, radix isatidis and the like. Aiming at the children fever, the Chinese patent medicine preparation can be used for treating both symptoms and root causes and is free of toxicity, harms and side effects to the human body, low in price, simple and convenient to prepare and wide in application prospect.

The invention relates to a bruceolic oil emulsion, a preparation method and application, belonging to the technical field of traditional Chinese medicine preparations. The novel bruceolic oil emulsion is designed by changing types and amounts of auxiliary materials, the auxiliary materials used in the bruceolic oil emulsion are low in price and small in amount, and the new preparation is relatively good in anti-tumor effect; the bruceolic oil emulsion consists of 0.5ml of bruceolic oil, 0.12ml of Tween-80, 0.125ml of glycerinum and the balance of sterile water, wherein the total amount is 5ml. The bruceolic oil emulsion provided by the invention has an anti-tumor effect superior to that of a common bruceolic oil emulsion injection in the market, the amount of the Tween-80 serving as one auxiliary material is half that of soybean lecithin in a conventional product, the amount of the Tween-80 is very low, and requirements on the amount of the Tween-80 in an injection can be met.

The invention relates to an Inula nervosa Wall oil capsule preparation, which is prepared from the following raw materials in parts by weight: 80 parts of Inula nervosa Wall, 25 parts of rhizoma anemarrhenae, 25 parts of costus root, 22 parts of curcuma aromatic, 20 parts of myrrh, 20 parts of prepared rehmannia root, 20 parts of tuckahoe, 18 parts of cortex albiziae, 18 parts of dandelion, 17 parts of rhizoma zingiberis, 15 parts of cistanche, 15 parts of cassia twig, 13 parts of root of common peony, 12 parts of rhizoma atractylodis, 12 parts of ligusticum wallichii, 10 parts of nux vomica, 10 parts of malt, 10 parts of radix aconiti preparata, 9 parts of peach kernel, 7 parts of liquorice, 7 parts of the seed of cowherb, 5 parts of teasel root and 5 parts of frankincense. The Inula nervosa Wall oil capsule preparation can treat both symptoms and root causes of rheumatoid arthritis, is harmless and non-toxic for a human body, does not have a side effect, has low price, is simple and convenient to prepare, and has a wide application prospect.

A method for processing infectious medical solid waste through radiation rays includes the steps of firstly, establishing a density data model according to data of infectious medical solid waste in anarea, and at least selecting three types of simulating materials different in density and uniform in texture for dosage distribution testing; secondly, placing the simulating materials and a dosage meter in a transmission device for radiation processing; thirdly, analyzing the radiation dosage distribution data in the simulating materials, and establishing the conversion relation between the absorption dosage minimum value and the monitoring position dosage; fourthly, placing the infectious medical solid waste and the dosage meter on the transmission device for radiation processing; fifthly,calculating the absorption amount minimum value accepted by the infectious medical solid waste according to the monitoring position dosage through the conversion relation, comparing the absorption amount minimum value with the accepted minimum radiation dosage required by sterilizing, taking out the infectious medical solid waste if the standard is reached, and executing the radiation again if thestandard is not reached. Thus, the infectious medical solid waste ray sterilizing process is standardized, the operating cost is reduced, and the reliability of the sterilizing effect is ensured.

The invention relates to a medicine composition for treating recurrent respiratory tract infection of children. The medicine composition is prepared from the following materials in parts by weight: 5 parts of ibuprofen, 20 parts of radix bupleuri, 20 parts of coptis chinensis, 18 parts of Chinese yam, 15 parts of bamboo leaf, 15 parts of radix zanthoxyli, 15 parts of astragalus membranaceus, 12 parts of pinellia ternate, 10 parts of trichosanthes kirilowii maxim, 10 parts of radix angelicae, 5 parts of red flower, 5 parts of radix curcumae, 3 parts of pomegranate bark and 3 parts of liquorice. By virtue of a regular medicine preparing method such as adding starch or edible cellulose into the materials, capsules, tablets or suspensoid can be prepared. The medicine composition can be used for treating both manifestation and root cause of recurrent respiratory tract infection and fever of children, and is non-toxic and harmless to a human body, low in cost, simple to prepare and wide in application prospect.

The invention belongs to the technical field of medicines and discloses a traditional Chinese medicine for fracture healing. The traditional Chinese medicine is prepared from the following components in parts by weight: 25 parts of lycopodium clavatum, 25 parts of Chinese mahonia stem, 25 parts of Polygonum multiflorum, 20 parts of ligusticum wallichii, 20 parts of Drynaria Rhizome, 17 parts of radix curcumae, 16 parts of Sappanwood, 16 parts of teasel root, 15 parts of Eucommia, 15 parts of safflower, 15 parts of Achyranthes, 15 parts of muskmelon seed, 13 parts of Coptis chinensis, 12 parts of cassia twig, 12 parts of radix angelicae, 10 parts of ginseng, 10 parts of Trichosanthes kirilowii, 10 parts of rhizoma curcumae, 8 parts of yam, 8 parts of dandelions and 5 parts of malts. The traditional Chinese medicine has a remarkable effect to the fracture healing and a wide application prospect.

The present invention relates to the technical field of food additives and particularly relates to a preservative composition and a use thereof. Every 1000 ml of solvent contains 0.005-0.1 g ethyl p-hydroxybenzoate and 0.005-0.1 g of ethylene diamine tetraacetic acid and is prepared by mixing the two materials. The preservative composition contains the ethyl p-hydroxybenzoate and the ethylene diamine tetraacetic acid at a mass ratio of 0.5-1 : 0.5-1. Compared with the prior art, the preservative composition can produce a strong inhibitory effect for the foodborne pathogen biofilm. The present invention provides a new use of the preservative composition in inhibiting the formation of foodborne pathogen biofilm. The preservative composition can be used for the preparations of drugs, food additives and feed additives inhibiting foodborne pathogen biofilm formation,, provides a new path for the control and clearance of biofilm in the food industry, and thereby provides a reliable protection for food safety.

The invention relates to an oxaprozin and a preparation technology thereof. The oxaprozin is prepared from the following raw materials according to parts by weight: 25 parts of oxaprozin, 300 parts of prepared Sichuan aconite root, 260 parts of notopterygium root, 165 parts of pawpaw and 100 parts of the bark of eucommia. With the common medicine preparation method, a starch active edible cellulose medicinal auxiliary material is added to obtain dosage forms, such as capsules, tablets, granules and the like. The compound oxaprozin medicine composition disclosed by the invention treats both principal and secondary aspect of rheumatoid arthritis, is non-toxic and harmless to the human body, does not have side effect, has the advantages of low price and wide application prospect and is simple and convenient to manufacture.

The invention relates to a medicament for allaying a fever of a child, and a preparation method thereof. The medicament is prepared from 30 parts of herba andrographitis, 25 parts of blackend swallowwort root, 25 parts of honeysuckle, 25 parts of fructus forsythia, 20 parts of folium mori, 20 parts of selfheal, 18 parts of cortex albiziae, 18 parts of astragalus membranaceus, 18 parts of scutellaria baicalensis, 15 parts of radix bupleuri, 15 parts of Chinese mahonia stem, 15 parts of ligusticum wallichii, 13 parts of semen raphani, 12 parts of fruit of Chinese wolfberry, 12 parts of liquorice, 10 parts of pinellia ternate, 10 parts of root of red-rooted salvia, 7 parts of peach kernel, 7 parts of cassia twig, 5 parts of root of common peony, 5 parts of rhizoma zingiberis and 3 parts of bamboo leaves. The medicament treats both symptoms and root causes aiming at the fever of the child, is free of poison and harm to a human body, free of side effect, low in price, and simple and convenient to prepare, and has a wide application prospect.

The invention relates to a bruceolic oil emulsion, a preparation method and application, belonging to the technical field of traditional Chinese medicine preparations. The novel bruceolic oil emulsion is designed by changing types and amounts of auxiliary materials, the auxiliary materials used in the bruceolic oil emulsion are low in price and small in amount, and the new preparation is relatively good in anti-tumor effect; the bruceolic oil emulsion consists of 0.5ml of bruceolic oil, 0.12ml of Tween-80, 0.125ml of glycerinum and the balance of sterile water, wherein the total amount is 5ml. The bruceolic oil emulsion provided by the invention has an anti-tumor effect superior to that of a common bruceolic oil emulsion injection in the market, the amount of the Tween-80 serving as one auxiliary material is half that of soybean lecithin in a conventional product, the amount of the Tween-80 is very low, and requirements on the amount of the Tween-80 in an injection can be met.